Vasculature-on-a-chip platform with innate immunity enables identification of angiopoietin-1 derived peptide as a therapeutic for SARS-CoV-2 induced inflammation
Microfluidic polymeric blood vessel captures the adverse effects of SARS-CoV-2 on vasculature and enables identification of a therapeutic peptide that abolished virus induced cytokine storm orchestrated by the immune cells.
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | 英语 |
| 出版: |
2022
|
| 在線閱讀: | https://doi.org/10.1039/d1lc00817j |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|